1 |
Elfeki MA, Singal AK, Kamath PS. Pharmacotherapies for Portal Hypertension: Current Status and Expanding Indications. Curr Hepatology Rep 2023. [DOI: 10.1007/s11901-023-00600-z] [Reference Citation Analysis]
|
2 |
Gao L, Zhang Y, Gao X, Xu L, Duan X. Prediction of esophageal varices in patients with hepatitis B-associated liver cirrhosis by non-invasive markers. Gastroenterology & Endoscopy 2023. [DOI: 10.1016/j.gande.2023.02.002] [Reference Citation Analysis]
|
3 |
Kulkarni AV, Premkumar M, Kumar K, Khan JA, Gora BA, Tirumalle S, Shaik S, Sharma M, Gupta R, Reddy ND, Rao PN. Nonselective beta‐blockers reduce mortality in patients with acute‐on‐chronic liver failure. Portal Hypertension & Cirrhosis 2022;1:15-22. [DOI: 10.1002/poh2.18] [Reference Citation Analysis]
|
4 |
Kulkarni AV, Anand AC. Non-invasive Tests, Portal Hypertension, and Beta-blockers: A Step Toward a Greener Environment! J Clin Exp Hepatol 2022;12:731-4. [PMID: 35677511 DOI: 10.1016/j.jceh.2022.03.011] [Reference Citation Analysis]
|